* an interview with the photogenic Horacio Guttierez (Microsoft) on the shifts in IP policy which he has overseen during his three years as Chief IP Officer;You can see the contents of this issue here.
* A sponsored piece, "IA metrics for the other IP market", on risk and reputation management (not recommended for people who don't like figures and diagrams);
* A report by finance editor Nigel Page on what Intellectual Ventures is up to, given (i) its brimming war chest and (ii) improving market conditions in the innovation investment sector;
* IAM journalist Sara-Jayne Adams writes ("Time for Big Pharma to be loud and proud") on the steps taken by GSK, in particular, to defend its record in terms of all-round positives and not merely profits.
"Where money issues meet IP rights". This weblog looks at financial issues for intellectual property rights: securitisation and collateral, IP valuation for acquisition and balance sheet purposes, tax and R&D breaks, film and product finance, calculating quantum of damages--anything that happens where IP meets money.
Wednesday, 5 August 2009
Recent publication
Labels:
IAM
Subscribe to:
Post Comments (Atom)
2 comments:
Jeremy,
Thanks for the write-up. Just to clarify one thing though: the article "IA metrics for the other IP market" is not a sponsored piece. IAM has a purely editorial relationship with the Intangible Asset Finance Society. We entered into this in order to supply readers with a regular supply of cutting-edge intangible asset management articles written by people who do not have a background in straight IP. We think this perspective is a valuable one. For its part, the IAFS gets regular exposure in a widely-read publication. All sponsored material in IAM is clearly labelled as "co-published editorial".
All the best,
Joff
Thanks for your clarification. I was obviously misled by the text accompanying the article, on p.47, which says "This article is sponsored by the Intangible Asset Finance Society's Secretariat". It doesn't say it's "co-published editorial" -- not in the article itself and not on the contents page.
Post a Comment